Serial Number
99926297
Owner
CellarisBio, LLCAttorney
Jianmin ZhouFirst Use Date
Jan 5, 2026
Filing Date
Jul 7, 2026
CELL DEL Trademark
Serial Number: 99926297
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Jianmin Zhou Law Offices of James Zhou
17700 Castleton St
Ste 568
City of Industry, CA 91748
United States
Trademark Details
Filing Date
July 7, 2026
Registration Date
Not Registered
First Use Anywhere
January 5, 2026
First Use in Commerce
January 5, 2026
Goods & Services
Reagents for cellular DNA-encoded library screening and selection; reagents for cellular ligand discovery assays; reagents for cell-based compound screening and target engagement assays; reagents for DNA-encoded library-based drug discovery; reagents for enrichment, identification, validation, and characterization of ligand-target interactions in cells; biochemical reagents for cellular screening assays; assay reagents for identifying bioactive compounds in living cells; reagents for affinity selection and molecular interaction analysis; nucleic acid-tagged chemical libraries; chemical preparations for scientific purposes; biochemical reagents for scientific use; proteins, enzymes, nucleic acids, and chemical reagents for scientific research use; diagnostic preparations for scientific and laboratory research use; reagents for therapeutics discovery and drug discovery research.
Research and development services in cellular DNA-encoded library drug discovery; research and development in cell-based ligand discovery and target identification; pharmaceutical drug discovery and development services; research and development in therapeutics discovery; research and development in small-molecule discovery using DNA-encoded libraries; research and development in cellular target engagement and compound validation; conducting cellular screening, affinity selection, hit identification, hit validation, and lead discovery for scientific and pharmaceutical research; technology research in therapeutics discovery and drug discovery platforms; pharmaceutical product development relating to small molecules, molecular glues, degraders, peptides, antibodies, and therapeutic modalities; research and development of therapeutic compounds targeting intracellular proteins, membrane proteins, protein complexes, transcription factors, and signaling proteins.